<p>Pharma giant AstraZeneca has struck a deal with Europe's Inclusive Vaccines Alliance to supply up to 400 million doses of an experimental COVID-19 vaccine.</p>.<p>The alliance forged by Germany, France, Italy and the Netherlands to speed up production of a coronavirus vaccine is set to take delivery by the end of 2020 of a vaccine being tested by the University of Oxford. The agreement struck Saturday aims to make the vaccine available to other European countries that wish to take part.</p>.<p><strong><a href="https://www.deccanherald.com/coronavirus-live-news-covid-19-latest-updates.html" target="_blank">CORONAVIRUS SPECIAL COVERAGE ONLY ON DH</a></strong></p>.<p>The cost is expected to be offset by funding from the governments.</p>.<p>AstraZeneca, an Anglo-Swedish company, recently completed similar agreements with Britain, the United States the Coalition for Epidemic Preparedness Innovations, and Gavi, the Vaccine Alliance for 700 million doses. A license also has been agreed with the Serum Institute of India for another 1 billion doses.</p>.<p>Other companies, including Moderna and Sanofi, are racing to develop and produce a vaccine against the new coronavirus, a step experts say will be crucial to easing restrictions on public life and preventing additional waves of infections. </p>
<p>Pharma giant AstraZeneca has struck a deal with Europe's Inclusive Vaccines Alliance to supply up to 400 million doses of an experimental COVID-19 vaccine.</p>.<p>The alliance forged by Germany, France, Italy and the Netherlands to speed up production of a coronavirus vaccine is set to take delivery by the end of 2020 of a vaccine being tested by the University of Oxford. The agreement struck Saturday aims to make the vaccine available to other European countries that wish to take part.</p>.<p><strong><a href="https://www.deccanherald.com/coronavirus-live-news-covid-19-latest-updates.html" target="_blank">CORONAVIRUS SPECIAL COVERAGE ONLY ON DH</a></strong></p>.<p>The cost is expected to be offset by funding from the governments.</p>.<p>AstraZeneca, an Anglo-Swedish company, recently completed similar agreements with Britain, the United States the Coalition for Epidemic Preparedness Innovations, and Gavi, the Vaccine Alliance for 700 million doses. A license also has been agreed with the Serum Institute of India for another 1 billion doses.</p>.<p>Other companies, including Moderna and Sanofi, are racing to develop and produce a vaccine against the new coronavirus, a step experts say will be crucial to easing restrictions on public life and preventing additional waves of infections. </p>